
Immogen Leadership
Meet the team, advisors, and governance guiding Immogen’s precision immunotherapy and partnering decisions.
Executive Team

Aarav Sharma
CEO

Mateo García
CTO

Zuri Ndlovu
Developer

Leila Haddad
Designer

Hiroshi Tanaka
Marketing

Amara Okafor
Social
About
Scientific Governance and Strategic Vision
Immogen is guided by an integrated executive team, scientific advisory board, and independent directors who collectively oversee strategy, risk, and clinical translation. Our governance emphasizes data rigor, ethical trial design, and transparent communication with partners, regulators, and patients. Advisory experts in immunology, oncology, and RNA therapeutics regularly review our pipeline, ensuring CD4see advances along a clear path from discovery to first-in-human studies and, ultimately, to commercial availability.